BioFire Defense COVID-19 Test 510(k) with Sample Expansion Option
Closed Special Notice Posted
- Solicitation number
- JA-20-04-0310
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Salt Lake City UT 84107 USA
Notice details come from SAM.gov. Updated .
Notice text
Research and development aimed at securing FDA 510(k) clearance under the Federal Food, Drug, and Cosmetic Act for BioFire Defense’s COVID-19 test.
Period of Performance: May 2020 to May 2021.
Optional Item: Research and development aimed at improving BioFire Defense’s COVID-19 test by extending its utility to an additional sample type; the current test is limited to nasopharyngeal samples in storage and transport media. Period of Performance: May 2020 to November 2020.
Files
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity